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Hansen’s disease is a chronic granulomatous
disease caused by Mycobacterium leprae, an acid-
fast bacillus that lives in the cytoplasm of macro-
phages and Schwann cells. Commonly affected areas
include the peripheral nervous system, skin, upper
respiratory tract, eyes, and testes. Patients may show
no signs of the disease for up to 20 years after
infection. The disease may present along a spectrum
of clinical manifestations ranging from lepromatous
leprosy to tuberculoid leprosy.1
The peripheral nervous system is often affected
first, as patients present with numbness and pares-
thesia but no visible lesions. Cutaneous lesions are
variable in presentation, depending on which pole
of disease the patient has, but may include papules,
nodules, and plaques. Lesions are typically hypo-
pigmented, erythematous, or copper colored, and
they may be associated with reduction or complete
loss of sensation and anhidrosis.2 Hansen’s disease
rarely presents with verrucous lesions. This case
report presents an unusual filiform verrucous pre-
sentation of Hansen’s disease on the plantar aspect of
the feet in a patient with lepromatous leprosy.
CASE REPORT
A 27-year-old man, originally from the Pacific
Islands, reported to the clinic with a 3-year history of
enlarging red-brown plaques and nodules over his
extremities and facewith mostly sparing of the trunk.
He also complained of thick, dry skin over the soles
of his feet and systemic complaints of weakness,
fatigue, arthralgias, night sweats, and hoarseness. He
had no prior medical problems and no forms of
immunosuppression. He reported a history of
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Case Reports 2016;2:105-7.when outside. There was no known history of
penetrating trauma to the feet.
On physical examination, he exhibited scaly,
brownish-red infiltrated nodules and plaques on
his face, ears, arms, and legs. He had loss of the
lateral third of his eyebrows and infiltration of
the skin of his forehead causing a leonine facies
appearance. His hands displayed multiple abrasions
secondary to insensitivity, and he was found to have
loss of temperature sensation over affected areas.
Palpation of his peripheral nerves found enlarged
ulnar and greater auricular nerves. On the plantar
aspect of his feet bilaterally were hyperkeratotic
scaly plaques with ulcerations and fissures (Fig 1).
His fingernails and toenails were thickened and
dystrophic. Histopathology from a biopsy of his right
arm was positive for a lymphohistiocytic infiltrate
with a grenz zone, and numerous acid-fast organisms
within histiocytes and nerves were seen on Fite’s
stain. A diagnosis of lepromatous leprosy was made
and he was started on a multidrug regimen of
rifampin, dapsone, and clofazimine for a planned
treatment course of at least 24 months. Dapsone was
later changed to clarithromycin secondary to
intolerance to dapsone. One week into therapy,
fever, night sweats, arthralgias, lower extremity
edema, and ulcerated subcutaneous nodules deve-
loped consistent with an early type II reaction. He
responded well to thalidomide and prednisone.
The etiology of the unusual appearance of his feet
was unknown at the time of presentation. After
treatment was initiated, much of the thick scale
cleared revealing soft, pink, filiform verrucous
papules (Fig 2). A fungal culture showed rare
Candida species; therefore, he was started on an
empiric trial of fluconazole and given clindamycin2352-5126
 2015 by the American Academy of Dermatology, Inc. Published
by Elsevier. All rights reserved. This is an open access article
under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).
http://dx.doi.org/10.1016/j.jdcr.2015.11.015
105
Fig 1. Before treatment, reddish brown indurated plaques and nodules were seen on the face,
arms, legs and dorsal feet while hyperkeratotic, scaly plaques were present on the soles of the
feet.
Fig 2. Soft, pink, and hyperpigmented verrucous papules
seen on the soles of the feet after several weeks of
multidrug treatment.
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with this regimen, a biopsy of the sole of the left foot
was taken, which showed thinning of the epidermis
with a lymphocytic infiltrate and numerous acid-fast
bacilli seen on Fite’s stain (Fig 3). A periodic
acideSchiff stain was negative, and no viral changes
were appreciated confirming the diagnosis of an
unusual filiform verrucous presentation of leprosy
involving the soles of the feet. His lesions continue toimprove on multidrug treatment combined with
keratolytic agents and meticulous foot care.DISCUSSION
Globally, Hansen’s disease is estimated to affect
more than 180,000 people.3 Its prevalence has
rapidly decreased since the widespread implemen-
tation of multidrug therapy. In the 1980s and early
1990s, the global burden of Hansen’s disease was
estimated at 11 to 15 million people. Lepromatous
leprosy typically presents with a symmetric eruption
of infiltrated erythematous macules, papules, nod-
ules, and plaques on the face, buttocks, and lower
extremities.1,4 Despite this large number of patients,
only 25 cases of verrucous lepromatous lesions have
been reported to date.5
Verrucous lepromatous lesions were first
described in 1897 at the First International
Conference on Leprosy.5 Since then, Patki6
described 18 cases of verrucous lesions in leprosy
and subdivided these into 3 distinct morphologic
types: (1) lesions having fingerlike projections and
resembling filiform warts, (2) thick hornlike
Fig 3. A, Numerous acid-fast bacilli. B and C, Predominantly lymphocytic infiltrate without
involvement of the epidermis and histiocytes with globoid inclusions. (A, Fite’s stain; B and C,
Hematoxylin-eosin stain; original magnifications: B, 34 and C, 320.)
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transverse fissures corresponding to the skin creases
of the anterior aspects of the ankles.6
The etiology of these verrucous lesions is unclear,
but case reports suggest that these lesions form in
areas of sensory loss. Patki6 suggests other risk
factors for verrucous development are anhidrosis
secondary to autonomic neuropathy and the use of
inexpensive shoes made of stiff plastic.6 The shoes
described by Patki6 are important in verrucous lesion
pathogenesis in that their rigid shape causes
repetitive friction at a particular site. Because of
lack of sensation, the patient is unaware of this
chronic irritation. Thus, it can be alleged that any
nidus for chronic irritation at an area of diminished
sensation increases the risk of verrucous papules and
plaques.6
Few previous case reports have described acral
verrucous lesions in patients with Hansen’s disease.
Most reports describe verrucous lesions of the lower
legs.5,6 Less commonly, the face, wrists, elbows,
and heels have also presented with lepromatous
verrucous lesions.5,7 Palmoplantar involvement is
rare in all cutaneous presentations of Hansen’s
disease. This rarity is thought to be a result of the
thicker epidermis and fibrofatty tissue in acral skin.
The thick epidermis acts as a mechanical barrier, and
the fibrofatty tissue ensures protection from heat
dissipation. Both factors increase the temperature of
the palms and soles, creating an unhospitable
environment for M leprae, which replicates best at
278C to 308C.1,8
Verrucous papules and plaques are rare cuta-
neous findings of Hansen’s disease. They typicallyoccur in advanced cases of lepromatous leprosy
on acral sites but do not constitute a distinct
morphologic subtype of disease.5 It is important to
consider leprosy in the differential diagnosis of
acral verrucous lesions in the right clinical context.
Correct diagnosis is essential, as verrucous lesions
are highly treatable with standard multidrug
therapy. In our patient, a biopsy specimen was
taken of the plantar feet, results of which showed
multiple acid-fast bacilli within histiocytes and
nerves. In cases in which fewer organisms are seen
histologically, polymerase chain reaction may be
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